Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Withdrawn × Mass Screening × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 30 Radiotherapy 21 Cisplatin 21 fludarabine 19 Paclitaxel 17 Nivolumab 16 Magnetic Resonance Spectroscopy 16 Carboplatin 15 pembrolizumab 14 fludarabine phosphate 14 Specimen Handling 13 Gemcitabine 13 Radiation 11 Biopsy 11 Docetaxel 10 Cytarabine 10 Melphalan 9 Filgrastim 9 Etoposide 9 Doxorubicin 9 Dexamethasone 9 Radiosurgery 8 Granulocyte Colony-Stimulating Factor 8 venetoclax 7 trametinib 7 ibrutinib 7 durvalumab 7 Sorafenib 7 Rituximab 7 Prednisone 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00837135 2016-08-17

GI-4000 With Adoptive Transfer in Pancreatic Cancer

University of Pennsylvania

Phase 1 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡